Table 1. Laboratory examination results (pre-op).
| Item | Results | Normal/abnormal | Reference range |
|---|---|---|---|
| Tumor marker | |||
| CyFRA21-1 (ng/mL) | 3.19 | – | 0.10–3.30 |
| CEA (ng/mL) | 0.795 | – | 0.00–5.00 |
| NSE (ng/mL) | 12.74 | – | 0.00–15.20 |
| Blood routine | |||
| WBC (×109/L) | 7.91 | – | 3.5–9.5 |
| HGB (g/L) | 144.0 | – | 115.0–150.0 |
| PLT (×109/L) | 263 | – | 100.0–350.0 |
| Liver function test | |||
| ALT (U/L) | 7.6 | – | 7–40 |
| AST (U/L) | 18.1 | – | 13–35 |
| AS/AL | 2.38 | – | 0–3 |
| CHE (U/L) | 8,806 | – | 5,320–12,920 |
| ALP (U/L) | 45. 8 | – | 35–100 |
| GGT (U/L) | 12.6 | – | 7–45 |
| LDH (U/L) | 166.2 | – | 120–250 |
| ALB (g/L) | 38.2 | – | 40–55 |
| GLOB (g/L) | 26.75 | – | 20–40 |
| GLU (mmol/L) | 6.96 | ↑ | 3.9–6.1 |
| CK (U/L) | 337 | ↑ | 40–200 |
| CRP (mg/L) | 166.27 | ↑ | 0–3 |
CyFRA21-1, cytokeratin-19-fragment; CEA, carcinoembryonic antigen; NSE, neuronspecific enolase; WBC, white blood cell count; HGB, hemoglobin; PLT, platelet count; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CHE, cholinesterase; ALP, alkaline phosphatase; GGT, gamma glutamine transferase; LDH, lactate dehydrogenase; ALB, albumin; GLOB, globulin; GLU, glucose in the blood; CK, creatine kinase; CRP, C-reactive protein.